Frank Taylor, MD
Allergy & Immunology · Madisonville, KYNPI 1295832913
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $664 and has fallen 70.1% since, to $199 in 2025. That places this record below the midpoint for allergy & immunology clinicians in KY, where the typical reported total is $7,092.
Across 85 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$187
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$155
- Regeneron Healthcare Solutions, Inc.$129
- Johnson & Johnson$120
- Baxter Healthcare$114
- Amgen$105
- plus $509 from 16 others
What the payments were for
- Food & beverage$1,29298%
- Education$282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $187 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $155 |
| Regeneron Healthcare Solutions, Inc. | 8 | $129 |
| Johnson & Johnson | 11 | $120 |
| Baxter Healthcare | 5 | $114 |
| Amgen | 7 | $105 |
| Sanofi | 5 | $90 |
| Grifols USA, LLC | 3 | $48 |
| Actelion Pharmaceuticals US, Inc. | 3 | $48 |
| AstraZeneca | 3 | $45 |
| Shire North American Group Inc | 2 | $44 |
| United Therapeutics Corporation | 2 | $37 |
| Astellas Pharma US Inc | 2 | $35 |
| Lundbeck LLC | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Inogen, Inc. | 2 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Abbott | 1 | $13 |
| Merck | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,319 in reported general payments places this provider in the 20th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 306 | $221,246 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 108 | $68,567 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $13,124 |
| Advair HfaFluticasone Propion/Salmeterol | 29 | $8,880 |
| Theophylline ErTheophylline Anhydrous | 85 | $6,987 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 307 | $5,365 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,693 |
| Varenicline Tartrate | 17 | $4,546 |
| Doxycycline Monohydrate | 302 | $4,078 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 51 | $3,630 |
| Ventolin HfaAlbuterol Sulfate | 46 | $2,845 |
| BreynaBudesonide/Formoterol Fumarate | 26 | $2,216 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $1,680 |
| Roflumilast | 16 | $1,044 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $1,024 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $187 | $239,063351 claims |
| AstraZenecaBreztri Aerosphere | $45 | $68,567108 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Madisonville
- Lee CloreOwensboro$841K
- James SublettLouisville$588K
- Hans OttoFlorence$381K
- Stephen PollardLouisville$301K
- Douglas LotzLouisville$199K
- James SublettLouisville$194K
- Timothy FranxmanLouisville$162K
- Jeremy JonesLouisville$149K
- Rajiv AroraLexington$144K
- Mark CorbettLouisville$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.